A detailed history of Spire Wealth Management transactions in Incyte Corp stock. As of the latest transaction made, Spire Wealth Management holds 146 shares of INCY stock, worth $10,827. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 127 14.96%
Holding current value
$10,827
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$65.08 - $83.38 $1,236 - $1,584
19 Added 14.96%
146 $10,000
Q3 2024

Oct 15, 2024

BUY
$57.33 - $68.61 $1,146 - $1,372
20 Added 18.69%
127 $8,000
Q2 2024

Jul 31, 2024

BUY
$51.18 - $63.75 $4,810 - $5,992
94 Added 723.08%
107 $6,000
Q1 2024

Apr 24, 2024

BUY
$56.55 - $66.59 $735 - $865
13 New
13 $0
Q3 2022

Nov 07, 2022

SELL
$66.18 - $82.86 $7,147 - $8,948
-108 Reduced 28.05%
277 $18,000
Q2 2022

Jul 22, 2022

SELL
$66.18 - $83.18 $17,802 - $22,375
-269 Reduced 41.13%
385 $29,000
Q1 2022

Apr 18, 2022

SELL
$66.02 - $79.71 $2,310 - $2,789
-35 Reduced 5.08%
654 $52,000
Q4 2021

Jan 14, 2022

BUY
$63.34 - $74.11 $37,307 - $43,650
589 Added 589.0%
689 $51,000
Q1 2021

May 21, 2021

BUY
$76.02 - $100.5 $7,602 - $10,050
100 New
100 $8,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.